Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-01

Clinical Trial Update: A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Crinone 8% Intravaginal Progesterone Gel 90 mg Daily for Luteal Support in In-Vitro Fertilization (LOTUS II) [Phase 3]

View source ↗

Summary

LOTUS II is a Phase 3 trial comparing oral dydrogesterone 30 mg daily to intravaginal progesterone gel for luteal support in IVF, with completed status and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CRINONE (Progesterone)
  • Dydrogesterone (dydrogesterone)

Snippet

Sponsor: Abbott | Conditions: Female Infertility | Phase 3 | Status: COMPLETED | Results posted: 2019-10-01